Cystografin (BRACCO DIAGNOSTICS INC)
Welcome to the PulseAid listing for the Cystografin drug offered from BRACCO DIAGNOSTICS INC. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | BRACCO DIAGNOSTICS INC |
| NON-PROPRIETARY NAME: | diatrizoate meglumine |
| SUBSTANCE NAME: | DIATRIZOATE MEGLUMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1970-11-03 |
| END MARKETING DATE: | 0000-00-00 |
Cystografin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cystografin from BRACCO DIAGNOSTICS INC |
| LABELER NAME: | BRACCO DIAGNOSTICS INC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/mL) |
| START MARKETING DATE: | 1970-11-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0270-0149_69967fe9-08bc-7365-6b64-0dd33824b69d |
| PRODUCT NDC: | 0270-0149 |
| APPLICATION NUMBER: | NDA010040 |
Other DIATRIZOATE MEGLUMINE Pharmaceutical Manufacturers / Labelers:
